Cargando…
State-of-Art of Cellular Therapy for Acute Leukemia
With recent clinical breakthroughs, immunotherapy has become the fourth pillar of cancer treatment. Particularly, immune cell-based therapies have been envisioned as a promising treatment option with curative potential for leukemia patients. Hence, an increasing number of preclinical and clinical st...
Autores principales: | Lee, Jong-Bok, Vasic, Daniel, Kang, Hyeonjeong, Fang, Karen Kai-Lin, Zhang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123829/ https://www.ncbi.nlm.nih.gov/pubmed/33925571 http://dx.doi.org/10.3390/ijms22094590 |
Ejemplares similares
-
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
por: Chen, Branson, et al.
Publicado: (2018) -
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib
por: Kang, Hyeonjeong, et al.
Publicado: (2021) -
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
por: Samra, Bachar, et al.
Publicado: (2020) -
Adoptive Cell Therapy for T-Cell Malignancies
por: Fang, Karen Kai-Lin, et al.
Publicado: (2022) -
Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade
por: Fang, Linan, et al.
Publicado: (2019)